Journal article

Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease

C Song, S Burgess, JD Eicher, CJ O'Donnell, AD Johnson, J Huang, M Sabater-Lleal, FW Asselbergs, D Tregouet, SY Shin, J Ding, J Baumert, T Oudot-Mellakh, L Folkersen, NL Smith, SM Williams, MA Ikram, ME Kleber, DM Becker, V Truong Show all

Journal of the American Heart Association | WILEY | Published : 2017

Open access

Abstract

Background--Plasminogen activator inhibitor type 1 (PAI-1) plays an essential role in the fibrinolysis system and thrombosis. Population studies have reported that blood PAI-1 levels are associated with increased risk of coronary heart disease (CHD). However, it is unclear whether the association reflects a causal influence of PAI-1 on CHD risk. Methods and Results--To evaluate the association between PAI-1 and CHD, we applied a 3-step strategy. First, we investigated the observational association between PAI-1 and CHD incidence using a systematic review based on a literature search for PAI-1 and CHD studies. Second, we explored the causal association between PAI-1 and CHD using a Mendelian ..

View full abstract

University of Melbourne Researchers